Pee Cee Cosma Sope Limited (PCCOSMA) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹790M
Fair value as of: Jul 5, 2026
From 26 valuation models · updated today
Share price −3.0% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹292.55 – ₹544.50 · fair‑value band ₹464.33 – ₹775.29 · the ₹298.65 price screens below the ₹619.81 fair value. As of Jul 5, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Pee Cee Cosma Sope Limited (PCCOSMA) currently trades at ₹298.65, while our model-based Fair Value estimate is ₹619.81 — implying the stock looks roughly 107.5% undervalued today. We read business quality at 55/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Pee Cee Cosma Sope Limited generated revenue of ₹1.6B at a net margin of 5.3%. Revenue grew 22.2% year over year. It earns a return on equity of 15.9%. Net debt stands at ₹5.6M. Fundamentals as of Jul 5, 2026
Our scenario range runs from ₹464.33 (bear case) to ₹775.29 (bull case); at ₹298.65, the current price sits below that range. The share trades about 46% below its 52-week high and 5% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -38% fair-value upside — at 108%, PCCOSMA screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.
About the company
Pee Cee Cosma Sope Limited manufactures and sells laundry soap, and detergent powder and cake in India. It also offers cleaning preparation, soap chips, toiletry, and other products. The company sells its products under the Doctor brand name. Pee Cee Cosma Sope Limited was founded in 1947 and is based in Agra, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Pee Cee Cosma Sope Limited reported revenue of ₹1.6B in FY2026 versus ₹927M in FY2022, a compound +14.3%/yr. Reported net income was ₹83.3M in FY2026, compounding +49.1%/yr from FY2022.
Is PCCOSMA fairly valued? → Check now
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 5, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | 2,590 MXN | 1,415 MXN | -45% |
| L'Oréal S.A LRLCF | $445.77 | $275.67 | -38% |
| Unilever PLC UNLYF | $59.34 | $46.11 | -22% |
| Colgate-Palmolive Company CPA | €77.60 | €36.69 | -53% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,122 | ₹677.55 | -68% |
| Reckitt Benckiser Group RBGLY | $12.41 | $17.31 | +39% |
| Henkel AG HENOY | $20.52 | $20.98 | +2% |
| Kimberly-Clark Corporation KMBB34 | R$530.90 | R$72.97 | -86% |
| Kenvue Inc KVUE | $18.05 | $11.24 | -38% |
| Church & Dwight Co CHDC34 | R$488.56 | R$53.25 | -89% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Pee Cee Cosma Sope Limited (PCCOSMA) undervalued?
What is the fair value of PCCOSMA?
What is the quality score of PCCOSMA?
What is the revenue of Pee Cee Cosma Sope Limited (PCCOSMA)?
What is the net profit margin of PCCOSMA?
Does Pee Cee Cosma Sope Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.